Vland Biotech released its semi-annual performance report, with a net profit attributable to the parent company of 26.72 million yuan, a year-on-year decrease of 8.98%

According to the Zhitong Finance APP, Vland Biotech (603739.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 652 million yuan, a year-on-year increase of 7.05%; net profit attributable to the parent company was 26.72 million yuan, a year-on-year decrease of 8.98%; net profit excluding non-recurring items was 16 million yuan, a year-on-year increase of 4.17%; basic earnings per share were 0.11 yuan